dc.creatorRubio Álvarez, Eduardo
dc.creatorAmaro, José
dc.creatorVillavicencio, Leonel
dc.date.accessioned2019-03-18T12:03:45Z
dc.date.available2019-03-18T12:03:45Z
dc.date.created2019-03-18T12:03:45Z
dc.date.issued2018
dc.identifierRev Chilena Infectol 2018; 35 (3): 309-311
dc.identifier07161018
dc.identifier10.4067/s0716-10182018000300309
dc.identifierhttps://repositorio.uchile.cl/handle/2250/167653
dc.description.abstractIn the last eleven months, we have diagnosed 9 cases of Histoplasmosis in our country. All patients affected were from endemic areas of South-America. Here, we wish to inform and prevent to all clinical laboratories from Chile about the presence of Histoplasma capsulatum in clinical samples. In the same way we want to prepare and raising awareness of the strengthening of biosecurity measures.
dc.languagesp
dc.publisherSociedad Chilena de Infectología
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Chilena de Infectología
dc.subjectDimorphic fungi
dc.subjectHistoplasma
dc.subjectHistoplasma capsulatum
dc.titleHistoplasma capsulatum: ¿un agente emergente para Chile?
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución